Callio Therapeutics
Boston, United States· Est.
Callio Therapeutics is a biotechnology company developing novel small molecule therapies for neurological disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $187M
About
Callio Therapeutics is a biotechnology company developing novel small molecule therapies for neurological disorders.
NeuroscienceSmall Molecules
Funding History
1Total raised:$187M
Seed$187M